Latest Breaking News On - ஒரு வாழ்க்கை ஆரோக்கியம் - Page 1 : vimarsana.com

Start-up Alife is operating in the intersection of AI and IVF

By Chloe Kent 13 May 2021 (Last Updated May 12th, 2021 17:18) Medical Device Network talks to Alife Health CEO Paxton Maeder-York about the growing role of AI during IVF procedures. The success rates for IVF are contingent on both the cause of infertility and the age of the person undergoing the procedure. Credit: Shutterstock Share Article In vitro fertilisation (IVF) is one of several techniques that can help the one in seven couples who will struggle to conceive. An egg is removed from the ovary of the person who will be carrying the child, and artificially fertilised with sperm in a laboratory. The embryo is then returned to the uterus. It can be carried out using eggs and sperm from donors, as well as a pregnant person and their partner, making it a viable option for individuals and couples experiencing infertility for a variety of different reasons.

This startup wants to bring clarity to the complex world of IVF – TechCrunch

This startup wants to bring clarity to the complex world of IVF About 180 million people globally suffer from infertility. In the United States, one in eight families have trouble conceiving. The statistics are only getting worse, as male infertility and miscarriages continue to increase. Alife Health, a San Francisco-based startup founded by Paxton Maeder-York, thinks it can help. The startup wants to use artificial intelligence to increase fertility outcomes. Specifically, it wants to optimize in vitro fertilization, a fertility treatment that requires a series of expensive and emotionally taxing procedures with varied success rates. Founded last year, the startup just raised a $9.5 million seed round, led by Lux Capital. Other investment firms include Amplo, IA Ventures and Springbank Collective, as well as angel investors such as Anne Wojcicki, the founder and CEO of 23andMe; Fred Moll, the founder of Intuitive Surgical and Auris; and Amira Yahyaoui, the founder of Mos and Sequoia Scout.

SFBT Tuesday Digest: Super-sizing Peninsula campus; Big health care bet - San Francisco Business Times

Fertility in Crisis: Alife Health Aims to Improve Health Equity and Outcomes Using AI

AI-enabled fertility company Alife scores $9.5M in Seed funding

Artificial intelligence fertility startup Alife announced today it has raised $9.5 million in Seed funding. Lux Capital led the round with participation from Amplo, IA Ventures and Springbank Collective. Also included in the raise were a number of angel investors, including Anne Wojcicki, the founder and CEO of 23andMe; Fred Moll, the founder of Intuitive Surgical and Auris; Amira Yahyaoui, the founder of Mos and Sequoia Scout; Arthur Patterson the founder of Accel; Dr. Tom Lee the founder of One Medical Group and Galileo Health; and the founders of Ramp and Headway. Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.